Dashboard
Manage Tickers

INBXInhibrx Biosciences, Inc.

Nasdaq inhibrx.com


$ 15.68 $ -0.89 (-5.36 %)    

Friday, 14-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 15.7
$ 16.64
$ 0.00 x 0
$ 0.00 x 0
$ 15.66 - $ 16.64
$ 13.85 - $ 18.95
193,964
na
0
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

inhibrx-biosciences-13g-filing-shows-viking-global-investors-lp-reported-a-123-stake-in-the-co-as-of-may-29-2024
Inhibrx Biosciences 13G Filing Shows Vikin...
06/07/2024 20:29:47

– SEC Filing

top-4-health-care-stocks-that-are-preparing-to-pump-this-month
Top 4 Health Care Stocks That Are Preparin...
06/05/2024 11:46:52

trading-halt-halt-status-updated-at-84000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:40:...
05/31/2024 12:40:03

inhibrx-approve-sale-of-inbrx-101-to-sanofi-sanofi-to-acquire-all-outstanding-shares-of-inhibrx-through-merger-and-each-inhibrx-stockholder-to-receive-30share
Inhibrx Approve Sale Of INBRX-101 To Sanof...
05/24/2024 20:04:05

inhibrx-q4-2023-gaap-eps-173-misses-104-estimate-sales-163m-beat-5000k-estimate
Inhibrx Q4 2023 GAAP EPS $(1.73) Misses $(...
02/28/2024 14:21:21

Inhibrx (NASDAQ:INBX) reported quarterly losses of $(1.73) per share which missed the analyst consensus estimate of $(1.04) by ...

french-drugmaker-sanofi-agrees-to-buy-inhibrxs-candidate-for-rare-genetic-indication-for-about-22b
French Drugmaker Sanofi Agrees To Buy Inhi...
01/23/2024 13:00:55

Sanofi's strategic acquisition of Inhibrx's INBRX-101, a alpha-1 antitrypsin therapy in a registrational trial. Learn a...

olympic-sponsor-sanofi-makes-major-play-in-rare-disease-arena-22-billion-acquisition-of-inhibrx-project
Olympic Sponsor Sanofi Makes Major Play In...
01/23/2024 12:46:00

Following the acquisition, New Inhibrx will continue to operate under the "Inhibrx" name, with Mark Lappe as Chairman a...

jmp-securities-downgrades-inhibrx-to-market-perform
JMP Securities Downgrades Inhibrx to Marke...
01/23/2024 09:34:28

JMP Securities analyst Reni Benjamin downgrades Inhibrx (NASDAQ:INBX) from Market Outperform to Market Perform.

Core News & Articles
Inhibrx Sells INBRX-101 To Sanofi For Up T...
01/23/2024 06:09:08

Inhibrx, Inc. shareholders will receive per share consideration of $30 per share in cash, a CVR equal to $5, plus 0.25 shares i...

jmp-securities-reiterates-market-outperform-on-inhibrx-maintains-27-price-target
JMP Securities Reiterates Market Outperfor...
11/20/2023 14:19:19

JMP Securities analyst Reni Benjamin reiterates Inhibrx (NASDAQ:INBX) with a Market Outperform and maintains $27 price target.

Core News & Articles
Watching Axos Financial; The Bear Cave New...
11/16/2023 15:34:17

https://thebearcave.substack.com/p/problems-at-axos-financial-ax?utm_campaign

inhibrx-q3-eps-110
Inhibrx Q3 EPS $(1.10)
11/09/2023 22:11:58

inhibrx-announces-preliminary-data-from-the-phase-1-trial-of-inbrx-109-for-the-treatment-of-ewing-sarcoma
Inhibrx Announces Preliminary Data From Th...
11/02/2023 13:20:33

Inhibrx, Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical company dedicated to the development of therapeutics for oncolo...

inhibrx-announces-chiesi-farmaceutici-spa-declined-to-exercise-its-option-for-ex-north-america-rights-to-develop-and-commercialise-inbrx-101
Inhibrx Announces Chiesi Farmaceutici S.p....
09/19/2023 20:01:17

15m-bet-on-domo-check-out-these-3-stocks-insiders-are-buying
$1.5M Bet On Domo? Check Out These 3 Stock...
08/31/2023 11:58:22

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

why-nio-are-trading-lower-by-over-7-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why NIO Are Trading Lower By Over 7%? Here...
08/29/2023 16:51:54

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a pate...

pdd-holdings-up-fintech-holding-big-lots-and-other-big-stocks-moving-higher-on-tuesday
PDD Holdings, UP Fintech Holding, Big Lots...
08/29/2023 14:33:40

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in...

inhibrx-announces-200m-private-placement-financing-in-the-pipe-co-is-selling-an-aggregate-of-3621314-shares-of-its-common-stock-at-a-price-of-1935-per-share
Inhibrx Announces $200M Private Placement ...
08/29/2023 13:03:24

 Inhibrx, Inc. (NASDAQ:INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company dedicated...

jmp-securities-maintains-outperform-rating-for-inhibrx-heres-what-you-need-to-know
JMP Securities Maintains Outperform Rating...
08/23/2023 17:01:28

jmp-securities-maintains-outperform-on-inhibrx-lowers-price-target-to-27
JMP Securities Maintains Outperform on Inh...
08/23/2023 11:07:24

JMP Securities analyst Reni Benjamin maintains Inhibrx (NASDAQ:INBX) with a Outperform and lowers the price target from $35 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)